Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management

Inclusion Criteria: * Provide signed and dated informed consent form * Willing to comply with all study procedures and be available for the duration of the study * Male or Female, at least 18 years of age * Currently taking or a candidate for opioid pain medication * Documented or recent complaint of pain within 90 days (location to be documented in the case report form) with initial date of onset Exclusion Criteria: * Severe hepatic or renal disease (where current pharmaceutical dosing is affected and/or requires adjustment of standard dosing prior to PGx testing) * Significant diminished mental capacity that is unable to understand the protocol, surveys and questionnaires; unable to read/write English or Spanish. * Recent febrile illness that precludes or delays participation by more than 1 month * Pregnancy or lactation * Participation in a clinical study that may interfere with participation in this study * Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study